Zhao, X.; Liu, R.; Chen, Y.; Hettinghouse, A.; Liu, C.
Cytosolic Phospholipase A2 Is Required for Fexofenadine’s Therapeutic Effects against Inflammatory Bowel Disease in Mice. Int. J. Mol. Sci. 2021, 22, 11155.
https://doi.org/10.3390/ijms222011155
AMA Style
Zhao X, Liu R, Chen Y, Hettinghouse A, Liu C.
Cytosolic Phospholipase A2 Is Required for Fexofenadine’s Therapeutic Effects against Inflammatory Bowel Disease in Mice. International Journal of Molecular Sciences. 2021; 22(20):11155.
https://doi.org/10.3390/ijms222011155
Chicago/Turabian Style
Zhao, Xiangli, Ronghan Liu, Yuehong Chen, Aubryanna Hettinghouse, and Chuanju Liu.
2021. "Cytosolic Phospholipase A2 Is Required for Fexofenadine’s Therapeutic Effects against Inflammatory Bowel Disease in Mice" International Journal of Molecular Sciences 22, no. 20: 11155.
https://doi.org/10.3390/ijms222011155
APA Style
Zhao, X., Liu, R., Chen, Y., Hettinghouse, A., & Liu, C.
(2021). Cytosolic Phospholipase A2 Is Required for Fexofenadine’s Therapeutic Effects against Inflammatory Bowel Disease in Mice. International Journal of Molecular Sciences, 22(20), 11155.
https://doi.org/10.3390/ijms222011155